.2 systems of poultry-keeping, including the use of living virulent agents to immunize against common respiratory infections. These created conditions ideal for intricate interactions between M. gallisepticum and other infections, notably infectious bronchitis virus (IBV) and certain serotypes of Escherichia coli, with Fahey-Crawley virus and Hwmophilus gallinarum of lesser significance. The incidence and severity of disease varies with the agent involved and the interval elapsing between exposure to M. gallisepticum and secondary infection. With IBV, immunity of the lower respiratory tract to M. gallisepticum is apparently overcome, and the organism spreads throughout, producing a chronic generalized infection. The most severe disease occurs when infection with IBV follows exposure to M. gallisepticum by one to three weeks. With E. coli, in addition to extensive respiratory disease, pericarditis and perihepatitis occur, due not to M. gallisepticum but to the coliform, which normally has only limited ability to produce disease. The No special medium was employed as there was no reason to suspect mycoplasma infection when the specimens were received. Growth occurred on the anaerobic blood agar cultures which were reincubated from three to five days since no satisfactory growth was seen earlier to account for the patients' infections. These mycoplasmas are not anaerobes but need moisture for growth. Five of the 7 cases were serologically positive, the other 2 were not tested.
Four of these cases have been reported in detail with methods of isolation and serological tests (Stokes 1955 Eaton's agent was first recognized twenty years ago in association with certain cases of human lower respiratory tract infection. Some of these cases were known to develop cold agglutinins or antibody to Streptococcus M.G. in their serum during the course of the illness, but cultivation of Eaton's agent was difficult and most diagnostic laboratories found specific tests impracticable.
Growth of the organism on a solid cell-free medium was reported in 1962 (Chanock, Hayflick & Barile 1962) and subsequently it was shown that broth cultures of the organism were a satisfactory source of specific complement-fixing antigen (Chanock, James et al. 1962 ). Production of a similar antigen for diagnostic use in this country was begun. The human sera used for evaluation of the antigen were chosen so that results of the tests would give some indication of the prevalence of infection in cases admitted to hospital. These results are the subject of this report.
Preparation of Complement-fixing Antigen A strain of Mycoplasma pneumoniw was kindly provided by Professor B P Marmion, then at the Public Health Laboratory, Leeds. It was grown first on agar in Petri dishes and then after several subcultures was adapted to growth in broth. The (1962) . When maximum growth had occurred the broth cultures were spun at 20,000 r.p.m. for two hours on a Model L Spinco centrifuge. The sediments were resuspended in a small volume of saline and washed by several cycles of low speed centrifugation and finally re-suspended in saline.
Section ofComparative Medicine
The antigen was strongly anticomplementary at this stage but heating in a boiling waterbath for ten to twenty minutes reduced this effect to a negligible level. The antigen was preserved with 1/10,000 Merthiolate and stored at +4°C.
The Complement-fixation Test The antigen was standardized by the chessboard method against a known positive human convalescent serum. Test sera were titrated against the optimum dilution of antigen as determined in the chessboard experiment. The complementfixing methods were identical with those used in the Public Health Laboratory Service for virus antigens (Bradstreet & Taylor 1962) . Sera were stored at -30°C and inactivated for thirty minutes at 57-58°C before use. Results were considered positive if there was a fourfold or greater rise in titre between paired sera. 
Source of Test Sera

Results and Discussion
Results of complement-fixation tests on the paired sera are shown in Table 1 by age and clinical category.
A rising CF antibody titre was found in 4-5 % of unselected cases with respiratory infection but where infection with M. pneumonie had been suspected on clinical grounds, 38 % of cases were positive. Three (1 3 %) cases with a nonrespiratory clinical diagnosis showed a rising titre of antibody, the clinical diagnoses in these cases were PUO, vaccinial encephalitis, and Bell's palsy, and further enquiries failed to elicit a history of respiratory infection in each case. In view of these findings most of the sera in each group were tested against a control antigen prepared from M. hominis type 1. None showed a rising titre, although there appeared to be some correlation between the presence of antibody to M. hominis type 1 and low (but unchanging) titres to M. pneumonia. All the rising CF antibody titres found in cases of nonrespiratory infection occurred in children, but a rather larger proportion of rising titres from cases of respiratory illness was found in adults than in children. The sera from suspected cases of M. pneumoniac infection were tested for antibody to Str. M.G. and rising titres were found in 10 cases (16%); all but one of these also showed a rising CF antibody titre to M. pneumonia. The one exception was a case with a high CF antibody titre in both specimens of serum. Results in the convalescent sera were analysed according to antibody titres and it was found that the number of cases in each group showing a rising titre was almost the same as those showing a convalescent titre of more than 1/80. This suggests that serological tests on a single convalescent specimen of serum may be of some diagnostic value, and it is evident that the rather low proportion of rising CF titres found in the unselected cases of respiratory infection was not due to delay in obtaining the acute stage specimen of serum. An analysis of CF antibody titres in the cases of nonrespiratory infections showed that 12 % of cases under 5 years of age had antibody levels of 1/20 or greater; between 5 and 15 years this rose to 32%, and over 15 years to 44 %, suggesting that infection occurs at all ages and that almost half the population eventually suffers an infection with M. pneumonia. The Serology of the Mycoplasmatacet As with any other group of microorganisms, serological methods can be applied to studies of the Mycoplasmatacee for two purposes, to detect the presence of specific antibody in the serum of an infected animal or human being and to identify organisms. The first is of obvious importance in the diagnosis of disease, but the second can also be of diagnostic value in distinguishing pathogenic from nonpathogenic types, especially as the cultural and biochemical properties of different species of mycoplasma are often closely similar. A third use of serological methods is the detection of specific antigen in the tissues of an infected host. The techniques which have been used are listed in Table 1 . Detection of Antibody Probably because of its value in the diagnosis of contagious bovine pleuropneumonia, complement fixation has been the method most widely applied to mycoplasma infections of other hosts. It has been used for the diagnosis of both genital and respiratory tract infections in man. It was also used in this laboratory to study the antibody response in several different mycoplasma infections of rats and mice. In such infections, as was not always possible in human genital disease, cultural and serological examinations could be carried out on the same animal and the progress of the infections followed. From these studies it was concluded that the detection by CFT of specific antibody in a serum was a reliable indication of the presence of mycoplasma infection in the host (Klieneberger-Nobel 1960 , Lemcke 1961 .
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At present, most diagnostic antigens consist of suspensions of whole organisms, i.e. crude mixtures of antigenic components; sometimes such suspensions tend to be anticomplementary e.g. M. pneumonie. Existing techniques could probably be improved and new ones introduced if methods were developed for the separation and purification of the antigenic components.
Detection of Antigen
This has only been carried out on tissues from cattle with contagious pleuropneumonia by methods which depend on the extraction of precipitating antigen (White 1958 , Turner 1962 . The newer indirect fluorescent antibody technique may be valuable for demonstrating mycoplasmas in host tissue. Hitherto, conventional staining methods have not proved satisfactory for this. The fluorescent antibody method has already been used successfully to demonstrate the organisms in tissue cultures and chick embryos (Clyde 1961 , Malizia et al. 1961 , Goodburn & Marmion 1962 .
Identification of Cultures
Although a number of serological techniques have been used to distinguish different types of mycoplasma, there has been a tendency to think in terms of host-specificity, and cross-testing between strains from different hosts has been rather limited. In this laboratory, there has been opportunity to examine strains from a wide variety of sources and to build up a collection of antisera for identification. Among 83 strains, 17 serological types have been distinguished by the complement fixation test (Table 2) , each type having been cross-tested against the others.
Most of these types corresponded to recognized species, but the umbilical type isolated by Ruiter
